{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:16:08Z","timestamp":1788146168242,"version":"build-2803163510"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10667-7","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:04:34Z","timestamp":1788141874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bidirectional impact between cardiovascular comorbidities and heart failure: an updated position paper from the Italian society of cardiology (SIC) working group on heart failure"],"prefix":"10.1007","volume":"31","author":[{"given":"Andrea","family":"Salzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Tricarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Mercurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Carella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Armentaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Badagliacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Matteo","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Crisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Dattilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariafrancesca","family":"Di Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fioretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo Maria","family":"Inciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Loria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Magr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano Maria","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Gabriele","family":"Tocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine Dario","family":"Vizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiuseppe","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barill\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Lloyd","family":"Dini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erberto","family":"Carluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Perrone","family":"Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savina","family":"Nodari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Palazzuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Correale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"10667_CR1","doi-asserted-by":"crossref","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKJJ (1996) The progression from hypertension to congestive heart failure. 275:1557\u20131562","DOI":"10.1001\/jama.1996.03530440037034"},{"key":"10667_CR2","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118:3272\u20133287","journal-title":"Cardiovasc Res"},{"key":"10667_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10741-023-10346-x","volume":"29","author":"AI Guaricci","year":"2024","unstructured":"Guaricci AI, Sturda F, Russo R, Basile P, Baggiano A, Mushtaq S et al (2024) Assessment and management of heart failure in patients with chronic kidney disease. Heart Fail Rev 29:379\u2013394","journal-title":"Heart Fail Rev"},{"key":"10667_CR4","doi-asserted-by":"publisher","first-page":"102411","DOI":"10.1016\/j.cpcardiol.2024.102411","volume":"49","author":"VTP Maryam","year":"2024","unstructured":"Maryam VTP (2024) Unraveling the complex pathophysiology of heart failure: insights into the role of renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS). Curr Probl Cardiol 49:102411","journal-title":"Curr Probl Cardiol"},{"key":"10667_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015472","author":"AA Manolis","year":"2023","unstructured":"Manolis AA, Manolis TA, Manolis AS (2023) Neurohumoral activation in heart failure. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242015472","journal-title":"Int J Mol Sci"},{"key":"10667_CR6","doi-asserted-by":"crossref","unstructured":"Di Palo KE, Barone NJJC (2022) Hypertension and heart failure: prevention, targets, and treatment. 40:237\u2013244","DOI":"10.1016\/j.ccl.2021.12.011"},{"key":"10667_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J et al (2016) Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387:957\u2013967","journal-title":"Lancet"},{"key":"10667_CR8","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D\u2019Agostino RB, Kannel WB et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068\u20133072","journal-title":"Circulation"},{"key":"10667_CR9","doi-asserted-by":"crossref","unstructured":"Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S et al (2014) Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b7 25 million people. 383:1899\u20131911","DOI":"10.1016\/S0140-6736(14)60685-1"},{"key":"10667_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/011573403X289572240206112303","volume":"20","author":"S Agress","year":"2024","unstructured":"Agress S, Sheikh JS, Ramos AAP, Kashyap D, Razmjouei S, Kumar J et al (2024) The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions. Curr Cardiol Rev 20:13\u201329","journal-title":"Curr Cardiol Rev"},{"key":"10667_CR11","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","volume":"64","author":"RJ Mentz","year":"2014","unstructured":"Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR et al (2014) Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64:2281\u20132293","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR12","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C et al (2024) 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 45:3912\u20134018","journal-title":"Eur Heart J"},{"key":"10667_CR13","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H et al (2024) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 45:3314\u20133414","journal-title":"Eur Heart J"},{"key":"10667_CR14","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/jch.14553","volume":"24","author":"H Miao","year":"2022","unstructured":"Miao H, Zou C, Yang S, Chia YC, Van Huynh M, Sogunuru GP et al (2022) Targets and management of hypertension in heart failure: focusing on the stages of heart failure. J Clin Hypertens (Greenwich) 24:1218\u20131225","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10667_CR15","doi-asserted-by":"publisher","first-page":"586183","DOI":"10.3389\/fcvm.2020.586183","volume":"7","author":"X Meng","year":"2020","unstructured":"Meng X, Xu X (2020) What Is the Ideal Blood Pressure Treatment Target for Primary Prevention and Management of Atrial Fibrillation? Front Cardiovasc Med 7:586183","journal-title":"Front Cardiovasc Med"},{"key":"10667_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10741-023-10350-1","volume":"29","author":"A Aimo","year":"2024","unstructured":"Aimo A, Camerini L, Fabiani I, Morfino P, Panichella G, Barison A et al (2024) Valvular heart disease in patients with cardiac amyloidosis. Heart Fail Rev 29:65\u201377","journal-title":"Heart Fail Rev"},{"key":"10667_CR17","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/ejhf.2532","volume":"24","author":"A Aimo","year":"2022","unstructured":"Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G et al (2022) Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies. Eur J Heart Fail 24:2342\u20132351","journal-title":"Eur J Heart Fail"},{"key":"10667_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejim.2019.10.008","volume":"71","author":"M Correale","year":"2020","unstructured":"Correale M, Paolillo S, Mercurio V, Limongelli G, Barilla F, Ruocco G et al (2020) Comorbidities in chronic heart failure: an update from Italian Society of Cardiology (SIC) Working Group on Heart Failure. Eur J Intern Med 71:23\u201331","journal-title":"Eur J Intern Med"},{"key":"10667_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.106457","volume":"140","author":"M Correale","year":"2025","unstructured":"Correale M, Salzano A, Tricarico L, Cittadini A, Crisci G, Dattilo G et al (2025) Non cardiovascular comorbidities in heart failure. An updated position paper from the Heart Failure Working Group of the Italian Society of Cardiology (SIC). Eur J Intern Med 140:106457","journal-title":"Eur J Intern Med"},{"key":"10667_CR20","doi-asserted-by":"crossref","unstructured":"Paulus WJ, Tsch\u00f6pe CJJACC (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. 62:263\u2013271","DOI":"10.1016\/j.jacc.2013.02.092"},{"key":"10667_CR21","doi-asserted-by":"crossref","unstructured":"Drazner MHJC (2011) The progression of hypertensive heart disease. 123:327\u2013334","DOI":"10.1161\/CIRCULATIONAHA.108.845792"},{"key":"10667_CR22","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. 42:3599\u20133726","DOI":"10.1093\/eurheartj\/ehab670"},{"key":"10667_CR23","volume":"30","author":"M Piepoli","year":"2026","unstructured":"Piepoli M, Rosano G, Abreu A, Adamo M, Attanasio A, Chioncel O, Cohen-Solal A, Filippatos G, Gerdts E, Gevaert A, Halle M, Jhund P, Kurpas D, Moura B, Parati G, Petrie MC, Shantsila E, Simpson M, Sudano I, Tokmakova M, Tomasoni D, Uchmanowicz I, Volterrani M, Metra M (2026) Prevention of heart failure. Eur Heart J 30:ehag362","journal-title":"Eur Heart J"},{"key":"10667_CR24","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","volume":"73","author":"SJ Greene","year":"2019","unstructured":"Greene SJ, Fonarow GC, DeVore AD, Sharma PP, Vaduganathan M, Albert NM et al (2019) Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol 73:2365\u20132383","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR25","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/ejhf.3208","volume":"26","author":"J Li","year":"2024","unstructured":"Li J, Chen Y, Wang Y, Liu X, Li P, He Y et al (2024) Impact of guideline-directed medical therapy on systolic blood pressure and cardiovascular outcomes in patients with heart failure and low blood pressure: A systematic review and meta-analysis. Eur J Heart Fail 26:1435\u20131442","journal-title":"Eur J Heart Fail"},{"key":"10667_CR26","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2023) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 44:3627\u20133639","journal-title":"Eur Heart J"},{"key":"10667_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1056\/NEJM199610103351504","volume":"335","author":"M Packer","year":"1996","unstructured":"Packer M, O\u2019Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN et al (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 335:1107\u20131114","journal-title":"N Engl J Med"},{"key":"10667_CR28","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/01.CIR.96.3.856","volume":"96","author":"JN Cohn","year":"1997","unstructured":"Cohn JN, Ziesche S, Smith R, Anand I, Dunkman WB, Loeb H et al (1997) Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation 96:856\u2013863","journal-title":"Circulation"},{"key":"10667_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/HJH.0000000000001777","volume":"36","author":"C Thomopoulos","year":"2018","unstructured":"Thomopoulos C, Parati G, Zanchetti A (2018) Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis. J Hypertens 36:1637\u20131647","journal-title":"J Hypertens"},{"key":"10667_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ejhf.1971","volume":"23","author":"M Vaduganathan","year":"2021","unstructured":"Vaduganathan M, Pareek M, Kristensen AMD, Biering-S\u00f8rensen T, Byrne C, Almarzooq Z et al (2021) Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy. Eur J Heart Fail 23:384\u2013392","journal-title":"Eur J Heart Fail"},{"key":"10667_CR31","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B et al (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370:1383\u20131392","journal-title":"N Engl J Med"},{"key":"10667_CR32","first-page":"777","volume-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial, vol 362. Lancet, London, England, pp 777\u2013781"},{"key":"10667_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1388-9842(99)00039-2","volume":"1","author":"JG Cleland","year":"1999","unstructured":"Cleland JG, Tendera M, Adamus J, Freemantle N, Gray CS, Lye M et al (1999) Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail 1:211\u2013217","journal-title":"Eur J Heart Fail"},{"key":"10667_CR34","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP et al (2019) Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med 381:1609\u20131620","journal-title":"N Engl J Med"},{"key":"10667_CR35","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359:2456\u20132467","journal-title":"N Engl J Med"},{"key":"10667_CR36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(25)02064-1","volume":"407","author":"M Azizi","year":"2026","unstructured":"Azizi M, Tuttle KR, Brown JM, Piskorz DL, Kario K, Williams B (2026) New drug therapies for hypertension. Lancet (London England) 407:1014\u20131028","journal-title":"Lancet (London England)"},{"key":"10667_CR37","doi-asserted-by":"publisher","first-page":"i4482","DOI":"10.1136\/bmj.i4482","volume":"354","author":"A Odutayo","year":"2016","unstructured":"Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA (2016) Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 354:i4482","journal-title":"BMJ"},{"key":"10667_CR38","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1177\/2047487317715769","volume":"24","author":"V Ruddox","year":"2017","unstructured":"Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE (2017) Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol 24:1555\u20131566","journal-title":"Eur J Prev Cardiol"},{"key":"10667_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5603\/CJ.a2022.0061","volume":"30","author":"I Koniari","year":"2023","unstructured":"Koniari I, Artopoulou E, Mplani V, Mulita F, Alexopoulou E, Chourdakis E et al (2023) Atrial fibrillation in heart failure patients: an update on renin-angiotensin-aldosterone system pathway blockade as a therapeutic and prevention target. Cardiol J 30:312\u2013326","journal-title":"Cardiol J"},{"key":"10667_CR40","first-page":"100309","volume":"33","author":"C Dye","year":"2023","unstructured":"Dye C, Dela Cruz M, Larsen T, Nair G, Marinescu K, Suboc T et al (2023) A review of the impact, pathophysiology, and management of atrial fibrillation in patients with heart failure with preserved ejection fraction. Am Heart J Plus 33:100309","journal-title":"Am Heart J Plus"},{"key":"10667_CR41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jchf.2023.11.016","volume":"12","author":"JA Keefe","year":"2024","unstructured":"Keefe JA, Garber R, McCauley MD, Wehrens XHT (2024) Tachycardia and Atrial Fibrillation-Related Cardiomyopathies: Potential Mechanisms and Current Therapies. JACC Heart Fail 12:605\u2013615","journal-title":"JACC Heart Fail"},{"key":"10667_CR42","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","volume":"203","author":"D Kotecha","year":"2016","unstructured":"Kotecha D, Chudasama R, Lane DA, Kirchhof P, Lip GY (2016) Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol 203:660\u2013666","journal-title":"Int J Cardiol"},{"key":"10667_CR43","doi-asserted-by":"publisher","first-page":"ii40","DOI":"10.1093\/europace\/euaa368","volume":"23","author":"DVM Verhaert","year":"2021","unstructured":"Verhaert DVM, Brunner-La Rocca HP, van Veldhuisen DJ, Vernooy K (2021) The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases. Europace 23:ii40\u2013ii5","journal-title":"Europace"},{"key":"10667_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2026.06.017","author":"K Cho","year":"2026","unstructured":"Cho K, Segan L, Anthony C, Kalman JM, Kistler PM, Prabhu S (2026) Left ventricular fibrosis in atrial fibrillation and heart failure with reduced ejection fraction: a comprehensive review of mechanisms, clinical implications, and therapeutic perspectives. Heart Rhythm. https:\/\/doi.org\/10.1016\/j.hrthm.2026.06.017","journal-title":"Heart Rhythm"},{"key":"10667_CR45","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.15420\/aer.2025.53","volume":"15","author":"BK Kantharia","year":"2026","unstructured":"Kantharia BK, Wu L, Hulsurkar MM, Karimzad K, Shah AN, Narasimhan B et al (2026) Atrial Cardiomyopathy and Atrial Fibrillation in Different Heart Failure Substrates. Arrhythm Electrophysiol Rev 15:e11","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10667_CR46","doi-asserted-by":"publisher","first-page":"e022833","DOI":"10.1161\/JAHA.121.022833","volume":"11","author":"PF Brady","year":"2022","unstructured":"Brady PF, Chua W, Nehaj F, Connolly DL, Khashaba A, Purmah YJV et al (2022) Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death. J Am Heart Assoc 11:e022833","journal-title":"J Am Heart Assoc"},{"key":"10667_CR47","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","volume":"47","author":"LG Olsson","year":"2006","unstructured":"Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ et al (2006) Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 47:1997\u20132004","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1056\/NEJMoa1008816","volume":"364","author":"AI Investigators","year":"2011","unstructured":"Investigators AI, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M et al (2011) Irbesartan in patients with atrial fibrillation. N Engl J Med 364:928\u2013938","journal-title":"N Engl J Med"},{"key":"10667_CR49","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","volume":"384","author":"D Kotecha","year":"2014","unstructured":"Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG et al (2014) Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet (London England) 384:2235\u20132243","journal-title":"Lancet (London England)"},{"key":"10667_CR50","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","volume":"45","author":"JS Healey","year":"2005","unstructured":"Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S et al (2005) Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 45:1832\u20131839","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR51","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","volume":"59","author":"K Swedberg","year":"2012","unstructured":"Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H et al (2012) Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J Am Coll Cardiol 59:1598\u20131603","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR52","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","volume":"39","author":"M Rienstra","year":"2018","unstructured":"Rienstra M, Hobbelt AH, Alings M, Tijssen JGP, Smit MD, Brugemann J et al (2018) Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J 39:2987\u20132996","journal-title":"Eur Heart J"},{"key":"10667_CR53","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993\u20131004","journal-title":"N Engl J Med"},{"key":"10667_CR54","doi-asserted-by":"publisher","first-page":"e022222","DOI":"10.1161\/JAHA.121.022222","volume":"10","author":"AK Pandey","year":"2021","unstructured":"Pandey AK, Okaj I, Kaur H, Belley-Cote EP, Wang J, Oraii A et al (2021) Sodium-Glucose Co-Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc 10:e022222","journal-title":"J Am Heart Assoc"},{"key":"10667_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11\u201321","journal-title":"N Engl J Med"},{"key":"10667_CR56","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.21037\/jtd-22-550","volume":"14","author":"M Wang","year":"2022","unstructured":"Wang M, Zhang Y, Wang Z, Liu D, Mao S, Liang B (2022) The effectiveness of SGLT2 inhibitor in the incidence of atrial fibrillation\/atrial flutter in patients with type 2 diabetes mellitus\/heart failure: a systematic review and meta-analysis. J Thorac Dis 14:1620\u20131637","journal-title":"J Thorac Dis"},{"key":"10667_CR57","doi-asserted-by":"publisher","first-page":"902923","DOI":"10.3389\/fcvm.2022.902923","volume":"9","author":"Z Yin","year":"2022","unstructured":"Yin Z, Zheng H, Guo Z (2022) Effect of Sodium-Glucose Co-transporter Protein 2 Inhibitors on Arrhythmia in Heart Failure Patients With or Without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Front Cardiovasc Med 9:902923","journal-title":"Front Cardiovasc Med"},{"key":"10667_CR58","doi-asserted-by":"publisher","first-page":"107424842311852","DOI":"10.1177\/10742484231185252","volume":"28","author":"Q Lou","year":"2023","unstructured":"Lou Q, Li L, Liu G, Li T, Zhang L, Zang Y et al (2023) Vericiguat reduces electrical and structural remodeling in a rabbit model of atrial fibrillation. J Cardiovasc Pharmacol Ther 28:10742484231185252","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10667_CR59","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bohm M et al (2021) Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med 385:1451\u20131461","journal-title":"N Engl J Med"},{"key":"10667_CR60","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jchf.2021.11.006","volume":"10","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, Vaduganathan M, Claggett BL, de Boer RA, DeMets D, Hernandez AF et al (2022) Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial. JACC Heart Fail 10:184\u2013197","journal-title":"JACC Heart Fail"},{"key":"10667_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2030183","volume":"384","author":"DL Bhatt","year":"2021","unstructured":"Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK et al (2021) Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. N Engl J Med 384:117\u2013128","journal-title":"N Engl J Med"},{"key":"10667_CR62","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","volume":"358","author":"D Roy","year":"2008","unstructured":"Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL et al (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667\u20132677","journal-title":"N Engl J Med"},{"key":"10667_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L et al (2018) Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 378:417\u2013427","journal-title":"N Engl J Med"},{"key":"10667_CR64","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","volume":"389","author":"C Sohns","year":"2023","unstructured":"Sohns C, Fox H, Marrouche NF, Crijns H, Costard-Jaeckle A, Bergau L et al (2023) Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. N Engl J Med 389:1380\u20131389","journal-title":"N Engl J Med"},{"key":"10667_CR65","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1093\/europace\/euaa179","volume":"22","author":"B Kirstein","year":"2020","unstructured":"Kirstein B, Neudeck S, Gaspar T, Piorkowski J, Wechselberger S, Kronborg MB et al (2020) Left atrial fibrosis predicts left ventricular ejection fraction response after atrial fibrillation ablation in heart failure patients: the Fibrosis-HF Study. Europace 22:1812\u20131821","journal-title":"Europace"},{"key":"10667_CR66","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","volume":"69","author":"D Kotecha","year":"2017","unstructured":"Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J et al (2017) Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure. J Am Coll Cardiol 69:2885\u20132896","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR67","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1093\/eurheartj\/ehy555","volume":"39","author":"M Brignole","year":"2018","unstructured":"Brignole M, Pokushalov E, Pentimalli F, Palmisano P, Chieffo E, Occhetta E et al (2018) A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. Eur Heart J 39:3999\u20134008","journal-title":"Eur Heart J"},{"key":"10667_CR68","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/CIRCULATIONAHA.106.623199","volume":"114","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF et al (2006) Navigating the crossroads of coronary artery disease and heart failure. Circulation 114:1202\u20131213","journal-title":"Circulation"},{"issue":"4","key":"10667_CR69","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/ajcp\/44.4.458","volume":"44","author":"JR Snoga","year":"1965","unstructured":"Snoga JR, Morgan RL, Lundberg GD (1965) Idiopathic prepuberal hypertrophy of the male breast. Histochemical evaluation and relation to gynecomastia and other disorders of the breast. Am J Clin Pathol 44(4):458\u2013463","journal-title":"Am J Clin Pathol"},{"key":"10667_CR70","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 45:3415\u20133537","journal-title":"Eur Heart J"},{"key":"10667_CR71","doi-asserted-by":"publisher","first-page":"e010805","DOI":"10.1161\/CIRCHEARTFAILURE.123.010805","volume":"17","author":"P Paolisso","year":"2024","unstructured":"Paolisso P, Gallinoro E, Belmonte M, Bertolone DT, Bermpeis K, De Colle C et al (2024) Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF. Circ Heart Fail 17:e010805","journal-title":"Circ Heart Fail"},{"key":"10667_CR72","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1093\/eurheartj\/ehab653","volume":"42","author":"A Sinha","year":"2021","unstructured":"Sinha A, Rahman H, Webb A, Shah AM, Perera D (2021) Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction. Eur Heart J 42:4431\u20134441","journal-title":"Eur Heart J"},{"key":"10667_CR73","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","volume":"39","author":"SJ Shah","year":"2018","unstructured":"Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS et al (2018) Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 39:3439\u20133450","journal-title":"Eur Heart J"},{"key":"10667_CR74","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2507270","volume":"25","author":"A Palazzuoli","year":"2024","unstructured":"Palazzuoli A, Severino P, D\u2019Amato A, Myftari V, Tricarico L, Correale M et al (2024) Distinct profiles and new pharmacological targets for heart failure with preserved ejection fraction. Rev Cardiovasc Med 25:270","journal-title":"Rev Cardiovasc Med"},{"key":"10667_CR75","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","volume":"382","author":"DJ Maron","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O\u2019Brien SM, Boden WE et al (2020) Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med 382:1395\u20131407","journal-title":"N Engl J Med"},{"key":"10667_CR76","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","volume":"364","author":"EJ Velazquez","year":"2011","unstructured":"Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A et al (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364:1607\u20131616","journal-title":"N Engl J Med"},{"key":"10667_CR77","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","volume":"374","author":"EJ Velazquez","year":"2016","unstructured":"Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA et al (2016) Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med 374:1511\u20131520","journal-title":"N Engl J Med"},{"key":"10667_CR78","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M et al (2024) 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J 45:3538\u20133700","journal-title":"Eur Heart J"},{"issue":"22","key":"10667_CR79","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/eurheartj\/ehaf080","volume":"46","author":"M Ryan","year":"2025","unstructured":"Ryan M, Petrie MC, Kontopantelis E, Dodd M, Tong G, Marquis-Gravel G, Docherty KF, Clayton T, Lansky AJ, Mamas MA, Rouleau JL, Velazquez EJ, Perera D (2025) Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis. Eur Heart J 46(22):2052\u20132062","journal-title":"Eur Heart J"},{"issue":"8","key":"10667_CR80","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.122.012527","volume":"16","author":"SE Fremes","year":"2023","unstructured":"Fremes SE, Marquis-Gravel G, Gaudino MFL, Jolicoeur EM, B\u00e9dard S, Masterson Creber R, Ruel M, Vervoort D, Wijeysundera HC, Farkouh ME, Rouleau JL, STICH3C Study Investigators (2023) STICH3C: rationale and study protocol. Circ Cardiovasc Interv 16(8):e012527","journal-title":"Circ Cardiovasc Interv"},{"issue":"36","key":"10667_CR81","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, Chieffo A, Christodorescu RM, Deaton C, Doenst T, Jones HW, Kunadian V, Mehilli J, Milojevic M, Piek JJ, Pugliese F, Rubboli A, Semb AG, Senior R, Ten Berg JM, Van Belle E, Van Craenenbroeck EM, Vidal-Perez R, Winther S, ESC Scientific Document Group (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 45(36):3415\u20133537","journal-title":"Eur Heart J"},{"key":"10667_CR82","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/clc.22716","volume":"40","author":"PB Sandesara","year":"2017","unstructured":"Sandesara PB, Hammadah M, Samman-Tahhan A, Kelli HM, O\u2019Neal WT (2017) Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction. Clin Cardiol 40:692\u2013696","journal-title":"Clin Cardiol"},{"key":"10667_CR83","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1253\/circj.CJ-14-1280","volume":"79","author":"Y Nakamura","year":"2015","unstructured":"Nakamura Y, Kunii H, Yoshihisa A, Takiguchi M, Shimizu T, Yamauchi H et al (2015) Impact of peripheral artery disease on prognosis in hospitalized heart failure patients. Circ J 79:785\u2013793","journal-title":"Circ J"},{"key":"10667_CR84","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0735-1097(01)01725-9","volume":"39","author":"R Kelly","year":"2002","unstructured":"Kelly R, Staines A, MacWalter R, Stonebridge P, Tunstall-Pedoe H, Struthers AD (2002) The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study. J Am Coll Cardiol 39:219\u2013224","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR85","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/S0735-1097(02)01740-0","volume":"39","author":"BD Duscha","year":"2002","unstructured":"Duscha BD, Annex BH, Green HJ, Pippen AM, Kraus WE (2002) Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol 39:1170\u20131174","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10667_CR86","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.120.046048","volume":"142","author":"J Steffel","year":"2020","unstructured":"Steffel J, Eikelboom JW, Anand SS, Shestakovska O, Yusuf S, Fox KAA (2020) The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease. Circulation 142(1):40\u201348","journal-title":"Circulation"},{"key":"10667_CR87","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ijcard.2012.11.033","volume":"168","author":"SC Inglis","year":"2013","unstructured":"Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA, Solomon SD et al (2013) Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. Int J Cardiol 168:1094\u20131101","journal-title":"Int J Cardiol"},{"key":"10667_CR88","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjcard.2011.03.057","volume":"108","author":"WS Jones","year":"2011","unstructured":"Jones WS, Clare R, Ellis SJ, Mills JS, Fischman DL, Kraus WE et al (2011) Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). Am J Cardiol 108:380\u2013384","journal-title":"Am J Cardiol"},{"key":"10667_CR89","doi-asserted-by":"publisher","first-page":"e018684","DOI":"10.1161\/JAHA.120.018684","volume":"10","author":"MD Samsky","year":"2021","unstructured":"Samsky MD, Hellkamp A, Hiatt WR, Fowkes FGR, Baumgartner I, Berger JS et al (2021) Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID. J Am Heart Assoc 10:e018684","journal-title":"J Am Heart Assoc"},{"key":"10667_CR90","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/01.CIR.85.4.1364","volume":"85","author":"DM Mancini","year":"1992","unstructured":"Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL et al (1992) Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85:1364\u20131373","journal-title":"Circulation"},{"key":"10667_CR91","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/1358863X10382946","volume":"15","author":"MF O\u2019Rourke","year":"2010","unstructured":"O\u2019Rourke MF, Safar ME, Dzau V (2010) The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med 15:461\u2013468","journal-title":"Vasc Med"},{"key":"10667_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/life14010030","author":"M De Luca","year":"2023","unstructured":"De Luca M, Crisci G, Armentaro G, Cicco S, Talerico G, Bobbio E et al (2023) Endothelial dysfunction and heart failure with preserved ejection fraction-an updated review of the literature. Life (Basel). https:\/\/doi.org\/10.3390\/life14010030","journal-title":"Life (Basel)"},{"key":"10667_CR93","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.15420\/cfr.2025.02","volume":"11","author":"E Carulli","year":"2025","unstructured":"Carulli E, Marozzi MS, Carella MC, Guaricci AI, Tarsia G, Vacca A et al (2025) Addressing Endothelial Dysfunction in Heart Failure: The Role of Endothelial Progenitor Cells and New Treatment Horizons. Card Fail Rev 11:e21","journal-title":"Card Fail Rev"},{"key":"10667_CR94","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijcard.2016.02.017","volume":"209","author":"AM Marra","year":"2016","unstructured":"Marra AM, Arcopinto M, Salzano A, Bobbio E, Milano S, Misiano G et al (2016) Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure. Int J Cardiol 209:114\u2013117","journal-title":"Int J Cardiol"},{"key":"10667_CR95","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ejhf.95","volume":"16","author":"P Hedberg","year":"2014","unstructured":"Hedberg P, Hammar C, Selmeryd J, Viklund J, Leppert J, Hellberg A et al (2014) Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: prevalence and association with location of arterial disease. Eur J Heart Fail 16:625\u2013632","journal-title":"Eur J Heart Fail"},{"key":"10667_CR96","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.amjcard.2006.09.102","volume":"99","author":"RP Ward","year":"2007","unstructured":"Ward RP, Goonewardena SN, Lammertin G, Lang RM (2007) Comparison of the frequency of abnormal cardiac findings by echocardiography in patients with and without peripheral arterial disease. Am J Cardiol 99:499\u2013503","journal-title":"Am J Cardiol"},{"key":"10667_CR97","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jtcvs.2017.12.061","volume":"155","author":"A Krawczyk-Ozog","year":"2018","unstructured":"Krawczyk-Ozog A, Holda MK, Bolechala F, Siudak Z, Sorysz D, Dudek D et al (2018) Anatomy of the mitral subvalvular apparatus. J Thorac Cardiovasc Surg 155:2002\u20132010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10667_CR98","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","volume":"65","author":"AW Asgar","year":"2015","unstructured":"Asgar AW, Mack MJ, Stone GW (2015) Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65:1231\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR99","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","volume":"12","author":"PA Grayburn","year":"2019","unstructured":"Grayburn PA, Sannino A, Packer M (2019) Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials. JACC Cardiovasc Imaging 12:353\u2013362","journal-title":"JACC Cardiovasc Imaging"},{"key":"10667_CR100","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.jacc.2019.02.061","volume":"73","author":"S Deferm","year":"2019","unstructured":"Deferm S, Bertrand PB, Verbrugge FH, Verhaert D, Rega F, Thomas JD et al (2019) Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week. J Am Coll Cardiol 73:2465\u20132476","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR101","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","volume":"103","author":"F Grigioni","year":"2001","unstructured":"Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ (2001) Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103:1759\u20131764","journal-title":"Circulation"},{"key":"10667_CR102","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jacc.2019.12.024","volume":"75","author":"F Namazi","year":"2020","unstructured":"Namazi F, van der Bijl P, Hirasawa K, Kamperidis V, van Wijngaarden SE, Mertens B et al (2020) Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Secondary Mitral Regurgitation. J Am Coll Cardiol 75:750\u2013758","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR103","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","volume":"97","author":"A Rossi","year":"2011","unstructured":"Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S et al (2011) Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 97:1675\u20131680","journal-title":"Heart"},{"key":"10667_CR104","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43:561\u2013632","journal-title":"Eur Heart J"},{"key":"10667_CR105","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"JF Obadia","year":"2018","unstructured":"Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N et al (2018) Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. N Engl J Med 379:2297\u20132306","journal-title":"N Engl J Med"},{"key":"10667_CR106","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM et al (2018) Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 379:2307\u20132318","journal-title":"N Engl J Med"},{"key":"10667_CR107","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1016\/j.jacc.2018.09.047","volume":"72","author":"PE Bartko","year":"2018","unstructured":"Bartko PE, Hulsmann M, Goliasch G (2018) Quantitative Definition of Severe Functional Mitral Regurgitation. J Am Coll Cardiol 72:2934\u20132935","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR108","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.jacc.2021.10.010","volume":"78","author":"PA Grayburn","year":"2021","unstructured":"Grayburn PA, Packer M (2021) The Complex Phenotypic Expressions of Functional Mitral Regurgitation. J Am Coll Cardiol 78:2422\u20132424","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR109","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa2314328","volume":"391","author":"SD Anker","year":"2024","unstructured":"Anker SD, Friede T, von Bardeleben RS, Butler J, Khan MS, Diek M et al (2024) Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation. N Engl J Med 391:1799\u20131809","journal-title":"N Engl J Med"},{"key":"10667_CR110","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/ehjci\/jeaa205","volume":"22","author":"JM Vieitez","year":"2021","unstructured":"Vieitez JM, Monteagudo JM, Mahia P, Perez L, Lopez T, Marco I et al (2021) New insights of tricuspid regurgitation: a large-scale prospective cohort study. Eur Heart J Cardiovasc Imaging 22:196\u2013202","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10667_CR111","first-page":"634","volume":"38","author":"M Arsalan","year":"2017","unstructured":"Arsalan M, Walther T, Smith RL 2nd, Grayburn PA (2017) Tricuspid regurgitation diagnosis and treatment. Eur Heart J 38:634\u2013638","journal-title":"Eur Heart J"},{"key":"10667_CR112","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","volume":"30","author":"WA Zoghbi","year":"2017","unstructured":"Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA et al (2017) Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30:303\u2013371","journal-title":"J Am Soc Echocardiogr"},{"key":"10667_CR113","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1093\/eurheartj\/ehad653","volume":"44","author":"RT Hahn","year":"2023","unstructured":"Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E et al (2023) Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints. Eur Heart J 44:4508\u20134532","journal-title":"Eur Heart J"},{"key":"10667_CR114","first-page":"157","volume":"21","author":"E Chorin","year":"2020","unstructured":"Chorin E, Rozenbaum Z, Topilsky Y, Konigstein M, Ziv-Baran T, Richert E et al (2020) Tricuspid regurgitation and long-term clinical outcomes. Eur Heart J Cardiovasc Imaging 21:157\u2013165","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10667_CR115","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jacc.2003.09.036","volume":"43","author":"J Nath","year":"2004","unstructured":"Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405\u2013409","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR116","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jchf.2023.07.020","volume":"11","author":"RT Hahn","year":"2023","unstructured":"Hahn RT, Brener MI, Cox ZL, Pinney S, Lindenfeld J (2023) Tricuspid Regurgitation Management for Heart Failure. JACC Heart Fail 11:1084\u20131102","journal-title":"JACC Heart Fail"},{"key":"10667_CR117","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P et al (2019) The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21:137\u2013155","journal-title":"Eur J Heart Fail"},{"key":"10667_CR118","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/europace\/euac034","volume":"24","author":"J Stassen","year":"2022","unstructured":"Stassen J, Galloo X, Hirasawa K, Marsan NA, van der Bijl P, Delgado V et al (2022) Tricuspid regurgitation after cardiac resynchronization therapy: evolution and prognostic significance. Europace 24:1291\u20131299","journal-title":"Europace"},{"key":"10667_CR119","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"S Hein","year":"2003","unstructured":"Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107:984\u2013991","journal-title":"Circulation"},{"key":"10667_CR120","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamacardio.2024.3486","volume":"9","author":"S Mengi","year":"2024","unstructured":"Mengi S, Januzzi JL Jr., Cavalcante JL, Avvedimento M, Galhardo A, Bernier M et al (2024) Aortic stenosis, heart failure, and aortic valve replacement. JAMA Cardiol 9:1159\u20131168","journal-title":"JAMA Cardiol"},{"key":"10667_CR121","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","volume":"57","author":"N Mewton","year":"2011","unstructured":"Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891\u2013903","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR122","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jcmg.2015.09.026","volume":"9","author":"M Berthelot-Richer","year":"2016","unstructured":"Berthelot-Richer M, Pibarot P, Capoulade R, Dumesnil JG, Dahou A, Thebault C et al (2016) Discordant Grading of Aortic Stenosis Severity: Echocardiographic Predictors of Survival Benefit Associated With Aortic Valve Replacement. JACC Cardiovasc Imaging 9:797\u2013805","journal-title":"JACC Cardiovasc Imaging"},{"key":"10667_CR123","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/j.jacc.2015.10.030","volume":"66","author":"RO Bonow","year":"2015","unstructured":"Bonow RO (2015) Asymptomatic Aortic Stenosis: It Is Not Simple Anymore. J Am Coll Cardiol 66:2839\u20132841","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR124","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.echo.2020.10.014","volume":"34","author":"F Fortuni","year":"2021","unstructured":"Fortuni F, Butcher SC, van der Kley F, Lustosa RP, Karalis I, de Weger A et al (2021) Left Ventricular Myocardial Work in Patients with Severe Aortic Stenosis. J Am Soc Echocardiogr 34:257\u2013266","journal-title":"J Am Soc Echocardiogr"},{"key":"10667_CR125","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/ehjci\/jez203","volume":"21","author":"R Manganaro","year":"2020","unstructured":"Manganaro R, Marchetta S, Dulgheru R, Sugimoto T, Tsugu T, Ilardi F et al (2020) Correlation between non-invasive myocardial work indices and main parameters of systolic and diastolic function: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 21:533\u2013541","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10667_CR126","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/heartjnl-2014-307154","volume":"101","author":"V Nguyen","year":"2015","unstructured":"Nguyen V, Cimadevilla C, Estellat C, Codogno I, Huart V, Benessiano J et al (2015) Haemodynamic and anatomic progression of aortic stenosis. Heart 101:943\u2013947","journal-title":"Heart"},{"key":"10667_CR127","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/0735-1097(93)90560-N","volume":"22","author":"B Villari","year":"1993","unstructured":"Villari B, Campbell SE, Hess OM, Mall G, Vassalli G, Weber KT et al (1993) Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 22:1477\u20131484","journal-title":"J Am Coll Cardiol"},{"key":"10667_CR128","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1161\/CIRCULATIONAHA.106.654210","volume":"115","author":"J Bergler-Klein","year":"2007","unstructured":"Bergler-Klein J, Mundigler G, Pibarot P, Burwash IG, Dumesnil JG, Blais C et al (2007) B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation 115:2848\u20132855","journal-title":"Circulation"},{"key":"10667_CR129","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/heartjnl-2015-307742","volume":"101","author":"BR Lindman","year":"2015","unstructured":"Lindman BR, Breyley JG, Schilling JD, Vatterott AM, Zajarias A, Maniar HS et al (2015) Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement. Heart 101:1382\u20131388","journal-title":"Heart"},{"key":"10667_CR130","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1161\/CIRCULATIONAHA.125.074425","volume":"151","author":"BR Lindman","year":"2025","unstructured":"Lindman BR, Pibarot P, Schwartz A, Oldemeyer JB, Su YR, Goel K et al (2025) Cardiac Biomarkers in Patients With Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial. Circulation 151:1550\u20131564","journal-title":"Circulation"},{"key":"10667_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14217549","author":"G Laterra","year":"2025","unstructured":"Laterra G, Agnello F, Strazzieri O, Reddavid C, Scalia L, Ingala S et al (2025) Management of asymptomatic severe aortic stenosis: current evidence and future directions. J Clin Med.2025 Oct 24;14(21):7549. https:\/\/doi.org\/10.3390\/jcm14217549","journal-title":"J Clin Med"},{"key":"10667_CR132","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/ejhf.2504","volume":"24","author":"M Merlo","year":"2022","unstructured":"Merlo M, Pagura L, Porcari A, Cameli M, Vergaro G, Musumeci B et al (2022) Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey. Eur J Heart Fail 24:1377\u20131386","journal-title":"Eur J Heart Fail"},{"key":"10667_CR133","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2023.09.026","volume":"122","author":"L Pagura","year":"2024","unstructured":"Pagura L, Porcari A, Cameli M, Biagini E, Canepa M, Crotti L et al (2024) ECG\/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study. Eur J Intern Med 122:68\u201377","journal-title":"Eur J Intern Med"},{"key":"10667_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14192249","author":"MM Dicorato","year":"2024","unstructured":"Dicorato MM, Basile P, Muscogiuri G, Carella MC, Naccarati ML, Dentamaro I et al (2024) Novel insights into non-invasive diagnostic techniques for cardiac amyloidosis: a critical review. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics14192249","journal-title":"Diagnostics (Basel)"},{"key":"10667_CR135","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/eurheartj\/ehaf667","volume":"47","author":"M Fontana","year":"2026","unstructured":"Fontana M, Aimo A, Emdin M, Porcari A, Solomon SD, Hawkins PN et al (2026) Transthyretin amyloid cardiomyopathy: from cause to novel treatments. Eur Heart J 47:54\u201363","journal-title":"Eur Heart J"},{"key":"10667_CR136","first-page":"900","volume":"25","author":"A Porcari","year":"2024","unstructured":"Porcari A, Chimenti C, Merlo M, Musca F, Vergaro G, Iacoviello M et al (2024) [Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC\/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]. G Ital Cardiol (Rome) 25:900\u2013920","journal-title":"G Ital Cardiol (Rome)"},{"key":"10667_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15052045","author":"I Dentamaro","year":"2026","unstructured":"Dentamaro I, Guida P, Belahnech Y, Dicorato MM, Basile P, Carella MC et al (2026) Cardiovascular prognosis in stable patients with cardiac amyloidosis: a novel and simple risk score. J Clin Med. https:\/\/doi.org\/10.3390\/jcm15052045","journal-title":"J Clin Med"},{"key":"10667_CR138","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/CIRCULATIONAHA.119.044574","volume":"141","author":"P Pibarot","year":"2020","unstructured":"Pibarot P, Salaun E, Dahou A, Avenatti E, Guzzetti E, Annabi MS et al (2020) Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial. Circulation 141:1527\u20131537","journal-title":"Circulation"},{"key":"10667_CR139","doi-asserted-by":"publisher","first-page":"1151803","DOI":"10.3389\/fcvm.2023.1151803","volume":"10","author":"R Scirpa","year":"2023","unstructured":"Scirpa R, Cittadini E, Mazzocchi L, Tini G, Sclafani M, Russo D et al (2023) Risk stratification in transthyretin-related cardiac amyloidosis. Front Cardiovasc Med 10:1151803","journal-title":"Front Cardiovasc Med"},{"key":"10667_CR140","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","volume":"24","author":"B Iung","year":"2003","unstructured":"Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW et al (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231\u20131243","journal-title":"Eur Heart J"},{"key":"10667_CR141","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.112.113993","volume":"126","author":"YS Hamirani","year":"2012","unstructured":"Hamirani YS, Dietl CA, Voyles W, Peralta M, Begay D, Raizada V (2012) Acute aortic regurgitation. Circulation 126:1121\u20131126","journal-title":"Circulation"},{"key":"10667_CR142","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2023-002319","author":"JC Reil","year":"2023","unstructured":"Reil JC, Saisho H, Jockwer A, Fujita B, Paluszkiewicz L, Reil GH et al (2023) Impact of heart rate, aortic compliance and stroke volume on the aortic regurgitation fraction studied in an ex vivo pig model. Open Heart. https:\/\/doi.org\/10.1136\/openhrt-2023-002319","journal-title":"Open Heart"},{"key":"10667_CR143","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jcmg.2025.09.022","volume":"19","author":"M Malahfji","year":"2026","unstructured":"Malahfji M, Saeed M, Nguyen DT, Kaolawanich Y, Lababidi H, Gabr EM et al (2026) Cardiac Remodeling and Outcomes of Patients With Combined Aortic and Mitral Regurgitation. JACC Cardiovasc Imaging 19:180\u2013193","journal-title":"JACC Cardiovasc Imaging"},{"key":"10667_CR144","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1161\/01.CIR.0000038498.59829.38","volume":"106","author":"HP Chaliki","year":"2002","unstructured":"Chaliki HP, Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ et al (2002) Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 106:2687\u20132693","journal-title":"Circulation"},{"issue":"38","key":"10667_CR145","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, R\u00e5degran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S, ESC\/ERS Scientific Document Group (2022) 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43(38):3618\u20133731","journal-title":"Eur Heart J"},{"key":"10667_CR146","doi-asserted-by":"crossref","unstructured":"Tichelbacker T, Dumitrescu D, Gerhardt F, Stern D, Wissmuller M (2019) Adam M,etal. Pulmonary hypertension and valvular heart disease. 44:491\u2013501","DOI":"10.1007\/s00059-019-4823-6"},{"issue":"3","key":"10667_CR147","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1002\/cph4.70168","volume":"16","author":"P Prabala","year":"2026","unstructured":"Prabala P, Raza F, Chesler NC (2026) Heart-Lung Interactions in Pulmonary Hypertension due to Heart Failure With Preserved Ejection Fraction. Compr Physiol 16(3):e70168","journal-title":"Compr Physiol"},{"issue":"19","key":"10667_CR148","doi-asserted-by":"publisher","first-page":"9631","DOI":"10.3390\/ijms26199631","volume":"26","author":"M Correale","year":"2025","unstructured":"Correale M, Mercurio V, Bevere EML, Pezzuto B, Tricarico L, Attanasio U, Raucci A, Ferrara AL, Loffredo S, Puteo C, Iacoviello M, Margaglione M, Brunetti ND, Tocchetti CG, Agostoni P, Mussolino C, Vinci MC (2025) Pathophysiology of Pulmonary Arterial Hypertension: Focus on Vascular Endothelium as a Potential Therapeutic Target. Int J Mol Sci 26(19):9631","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10667_CR149","doi-asserted-by":"publisher","first-page":"e70187","DOI":"10.1002\/cph4.70187","volume":"16","author":"ES Tarras","year":"2026","unstructured":"Tarras ES, Arun AS, Joseph P, Heerdt PM, Singh I (2026) Right Ventricular End-Ejection Pressure Predicts Mortality in Patients With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Compr Physiol 16(3):e70187","journal-title":"Compr Physiol"},{"issue":"19","key":"10667_CR150","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/CIRCULATIONAHA.126.079918","volume":"153","author":"M Gomberg-Maitland","year":"2026","unstructured":"Gomberg-Maitland M, Tedford RJ, Langleben D, Rosenkranz S, Miller B, Jones AD, Urbinati A, McMullan CJ, Cornell AG, Vachiery JL (2026) Sotatercept for combined post- and precapillary pulmonary hypertension associated with heart failure: results from the phase 2, randomized, placebo-controlled CADENCE study. Circulation 153(19):1446\u20131459","journal-title":"Circulation"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10667-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10667-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10667-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:11:24Z","timestamp":1788145884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10667-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10667"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10667-7","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"100"}}